en
E-mail us
Extended package to GMP and beyond
Why Analytical Method Development and Transfer is required?
Why Analytical Method Development and Transfer is required?

Well-developed analytical methods are required to characterize quality attributes of biologics. These analytical methods also help to understand the critical process parameters and to minimize their impact on accuracy and precision. Biologics analytical method development and validation could be intricate, labor-intensive, and expensive in nature. An in-depth knowledge of FDA, ICH, and regulatory expectations along with the application of advanced instrumentation is critical to developing robust, efficient, and accurate analytical methods. These methods should encompass the regulatory domains of identity, strength, purity, stability, safety, and potency of biologics at every stage of the drug development.


According to FDA, EU, ICH Q2(R1), and ICH Q14 guidelines, analytical methods are divided into two categories, compendial and Non-compendial methods. The following table shows a panel of tests that are conducted as part of the analytical method development paradigm:

Extended package to GMP and beyond
Achieve Your Success with Our Expertise
Contact Us
bd_global@crystalpharmatech.com +1-609-604-8303
U.S
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China, 215123
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
bd_global@crystalpharmatech.com +1-609-604-8303